Mr. Speaker, that one product that is produced by Sandoz is not used or sold in Canada. The FDA notified Sandoz because Sandoz provides that drug to the United States.
The problem escalated because there was a fire at the Sandoz factory. Late notification from Sandoz to the provincial health authorities has created this situation. We are working with the provincial and territorial health ministries to respond to the situation.
At the same time I would encourage members of the House to read today's press release stating that members of Canada's pharmaceutical industry have come together to address the drug shortages in Canada.
I am encouraged by the response we are receiving from industry to provide timely and accurate information to the provinces and territories, pharmacists, medical associations, and all stakeholders involved to deal with drug shortages or anticipated drug shortages across the country. This is a work in progress.
What we saw with Sandoz has resolved that we need to do this as quickly as possible.